Trial
NCT03812562
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
Bristol-Myers Squibb; National Cancer Institute (NCI)
Condition
Hepatocellular Carcinoma
Intervention
Nivolumab
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-21